Publication | Open Access
Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast Cancer
11
Citations
72
References
2023
Year
Riluzole may offer therapeutic benefits in diverse ER+ breast cancers, including lobular breast cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1